NCT01390038

Brief Summary

The purpose of this study is to demonstrate safety and efficacy of the Simpliciti Shoulder System in total shoulder arthroplasty.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
157

participants targeted

Target at P25-P50 for phase_3

Timeline
Completed

Started Jul 2011

Typical duration for phase_3

Geographic Reach
1 country

14 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 26, 2011

Completed
1 month until next milestone

Study Start

First participant enrolled

July 1, 2011

Completed
7 days until next milestone

First Posted

Study publicly available on registry

July 8, 2011

Completed
3.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2014

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2014

Completed
1.4 years until next milestone

Results Posted

Study results publicly available

April 14, 2016

Completed
Last Updated

April 25, 2023

Status Verified

April 1, 2023

Enrollment Period

3.3 years

First QC Date

May 26, 2011

Results QC Date

February 16, 2016

Last Update Submit

April 21, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • Device Success Rate

    A subject is a Patient Success at 24-months if: 1. There is NO continuous radiolucent line around the prosthesis; and 2. The adjusted Constant Score is \> 85 (successful outcome); and 3. They did not have revision surgery; and 4. They did not have a system-related serious adverse event.

    24 months

Secondary Outcomes (6)

  • Quality of Life

    24 months

  • Range of Motion

    24 months

  • Strength

    24 months

  • Device Parameters

    24 months

  • American Shoulder and Elbow Surgeon Score

    24 Months

  • +1 more secondary outcomes

Study Arms (1)

Simpliciti™ Shoulder System

EXPERIMENTAL

The Simpliciti™ Shoulder System is intended for Total Shoulder Arthroplasty of the shoulder.

Device: Simpliciti™ Shoulder System

Interventions

Total shoulder arthroplasty system

Simpliciti™ Shoulder System

Eligibility Criteria

Age22 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adult subject 22 years or older
  • Clinical indication for total shoulder replacement due to primary diagnosis of arthritis. Primary arthritis for this study includes osteoarthritis, and/or traumatic arthritis.
  • Scapula and proximal humerus must have reached skeletal maturity
  • Subject with a Constant Score ≥ 20
  • Willing and able to comply with the protocol
  • Willing and able to sign the informed consent (or the Legally Authorized Representative will sign for the subject)

You may not qualify if:

  • Lack of sufficient sound bone to seat and support the implant such as:
  • Rapid joint destruction, marked bone loss or bone resorption;
  • Destruction of the proximal humerus that precludes rigid fixation of the humeral component; and
  • Osteomalacia
  • Metal allergies or sensitivity, including a known allergic reaction to implant metals (e.g., nickel) or polyethylene
  • Infection at or near the site of implantation, including:
  • Glenohumeral joint infection
  • Osteomyelitis
  • Distant or systemic infection
  • Medical conditions or balance impairments that could lead to falls
  • Prior open shoulder surgery on the shoulder to be treated in the study including failed rotator cuff surgery, but excluding successful shoulder arthroscopy
  • Any full thickness rotator cuff tear at the time of surgery or a nonfunctional rotator cuff
  • Excessive glenoid bone loss defined by preoperative computed tomography (CT) scans of the shoulder which show insufficient glenoid bone, or insufficient bone identified at the time of surgery
  • Metabolic disorders which may impair bone function
  • Nonfunctional deltoid muscle
  • +10 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (14)

Saint Agnes Medical Center

Fresno, California, 93720, United States

Location

Grossmont/Sharp Hospital

La Mesa, California, 91942, United States

Location

Yale University School of Medicine

New Haven, Connecticut, 06520, United States

Location

Rush Hospital

Chicago, Illinois, 60612, United States

Location

Beverly Hills Orthopaedic Surgery

Beverly Hills, Michigan, 48025, United States

Location

Munson Medical Center

Traverse City, Michigan, 49684, United States

Location

Sports and Orthopaedic Specialists

Edina, Minnesota, 55439, United States

Location

University of Missouri-Columbia

Columbia, Missouri, 65212, United States

Location

Bassett Healthcare Network Research Institute

Cooperstown, New York, 13326, United States

Location

Cleveland Clinic

Euclid, Ohio, 44119, United States

Location

The Center

Bend, Oregon, 97701, United States

Location

Medical University of South Carolina

Charleston, South Carolina, 29425, United States

Location

Knoxville Orthopaedic Clinic

Knoxville, Tennessee, 37917, United States

Location

Aurora Medical Center - Grafton

Grafton, Wisconsin, 53024, United States

Location

Results Point of Contact

Title
Josh Myers
Organization
Tornier/Wright Medical

Publication Agreements

PI is Sponsor Employee
No
Restriction Type
OTHER
Restrictive Agreement
Yes

Study Design

Study Type
interventional
Phase
phase 3
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 26, 2011

First Posted

July 8, 2011

Study Start

July 1, 2011

Primary Completion

November 1, 2014

Study Completion

December 1, 2014

Last Updated

April 25, 2023

Results First Posted

April 14, 2016

Record last verified: 2023-04

Locations